article thumbnail

tk

Broad Institute

Carpenter notes that she is satisfied seeing people expand on her work on Cell Painting and CellProfiler, saying “in the end, none of the work matters if biologists aren't adapting it in their labs for the myriad of disease areas that people work on.”

article thumbnail

An industry leader’s perspective on the complexity of scientific data

Drug Target Review

Data-driven discovery As with many early-stage biotech companies, Five Alarm Bio is highly data-driven, producing vast amounts of experimental data through cell-based assays and phenotypic screening.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

Inspired by her time at GSK, Millie pursued a PhD at the University of Cambridge investigating the signalling pathways that drive cancer cell growth using in-vitro cell based assays and biochemical analysis. Driven by an interest in drug discovery Millie joined AstraZeneca after completion of her PhD at the end of 2020.